Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 703

1.
2.
4.

In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.

Tsang J, Jiang S, Tanriver Y, Leung E, Lombardi G, Lechler RI.

Int Immunopharmacol. 2006 Dec 20;6(13-14):1883-8.

PMID:
17161341
5.

T cell-associated CD18 but not CD62L, ICAM-1, or PSGL-1 is required for the induction of chronic colitis.

Ostanin DV, Furr KL, Pavlick KP, Gray L, Kevil CG, Shukla D, D'Souza D, Hoffman JM, Grisham MB.

Am J Physiol Gastrointest Liver Physiol. 2007 Jun;292(6):G1706-14.

6.

Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo.

Yi LA, Hajialiasgar S, Chuang E.

Int Immunol. 2004 Apr;16(4):539-47.

7.
8.

Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.

van Seventer GA, Newman W, Shimizu Y, Nutman TB, Tanaka Y, Horgan KJ, Gopal TV, Ennis E, O'Sullivan D, Grey H, et al.

J Exp Med. 1991 Oct 1;174(4):901-13.

9.

The phenotype and survival of antigen-stimulated transgenic CD4 T cells in vivo: the influence of persisting antigen.

Yang CP, Sparshott SM, Duffy D, Garside P, Bell EB.

Int Immunol. 2006 Apr;18(4):515-23.

10.

CD7 and CD28 are required for murine CD4+CD25+ regulatory T cell homeostasis and prevention of thyroiditis.

Sempowski GD, Cross SJ, Heinly CS, Scearce RM, Haynes BF.

J Immunol. 2004 Jan 15;172(2):787-94.

11.

IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.

Zhang X, Koldzic DN, Izikson L, Reddy J, Nazareno RF, Sakaguchi S, Kuchroo VK, Weiner HL.

Int Immunol. 2004 Feb;16(2):249-56.

13.
14.

B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.

Yadav D, Judkowski V, Flodstrom-Tullberg M, Sterling L, Redmond WL, Sherman L, Sarvetnick N.

J Immunol. 2004 Sep 15;173(6):3631-9.

15.

Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression.

Hiura T, Kagamu H, Miura S, Ishida A, Tanaka H, Tanaka J, Gejyo F, Yoshizawa H.

J Immunol. 2005 Oct 15;175(8):5058-66.

16.

Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G, Rubin SC, Kaiser LR, June CH.

Cancer Res. 2001 Jun 15;61(12):4766-72.

17.
19.

Potent effector function of tumor-sensitized L-selectin(low) T cells against subcutaneous tumors requires LFA-1 co-stimulation.

Seeley BM, Barthel SW, To WC, Kjaergaard J, Shu S, Plautz GE.

Otolaryngol Head Neck Surg. 2001 Apr;124(4):436-41.

PMID:
11283503
20.

Early events in peripheral regulatory T cell induction via the nasal mucosa.

Unger WW, Hauet-Broere F, Jansen W, van Berkel LA, Kraal G, Samsom JN.

J Immunol. 2003 Nov 1;171(9):4592-603.

Items per page

Supplemental Content

Support Center